Suzetrigine-evoked analgesia is potentiated by Nav1.7 null-related opioid mechanisms.
Eva Villalba Riquelme, Olena Didenko, Sam Gossage…·John N. Wood
The paper investigates how Nav1.7 loss enhances opioid signaling and analgesia, showing that suzetrigine-evoked analgesia is potentiated by RGS antagonists and low-dose morphine in inflammatory pain models.